First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation

EuroIntervention. 2018 Sep 20;14(7):758-761. doi: 10.4244/EIJ-D-18-00440.


Here we describe the first implantation of the novel bicavally anchored Tricento transcatheter heart valve via the transvenous transfemoral access in a 74-year-old woman with severe tricuspid regurgitation and holosystolic hepatic vein backflow. Following successful implantation, caval vein regurgitant volume was reduced leading to symptomatic and clinical improvement at three-month follow-up. The Tricento device represents a promising, novel therapeutic option for patients with severe tricuspid regurgitation who are not candidates for open heart surgery.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cardiac Catheterization
  • Female
  • Heart Valve Prosthesis Implantation*
  • Heart Valve Prosthesis*
  • Humans
  • Prosthesis Design
  • Treatment Outcome
  • Tricuspid Valve Insufficiency* / surgery